Advancing Translation Inhibition as an ADC MOA: Potency and ICD From a Novel Payload

• Clarifying translation inhibition as the MOA of septacidin
• Design and optimization of linker-payload technology for septacidin analogues
• Demonstrating strong ICD and in vivo efficacy from proof of concept ADCs

Speakers:

Chris Neumann

Senior Director ADC Chemistry

Pfizer